Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-446279
Filing Date
2016-02-02
Accepted
2016-02-01 17:31:17
Documents
2
Effectiveness Date
2016-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d125003d8k.htm DEFA14A 14406
2 EX-99.1 d125003dex991.htm EX-99.1 30573
  Complete submission text file 0001193125-16-446279.txt   45998
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 161378464
SIC: 2836 Biological Products, (No Diagnostic Substances)